Brief: Genxone Signs Letter Of Intent With gMendel ApS
25/01/2022 15:44
Jan 25 (Reuters) - Genxone SA GX1.WA :
* SIGNS LETTER OF INTENT WITH GMENDEL APS ON COOPERATION IN
RELATION TO GENETIC DISORDER DIAGNOSTICS
* PARTIES AIM TO JOINTLY USE THEIR EXISTING TECHNOLOGY,
KNOW-HOW
AND ADAPT TOOLS TO MARKET DEMAND
* PARTIES ARE ALSO CONSIDERING COOPERATION IN RELATION TO
INTRODUCING GMENDEL APS TECHNOLOGY ON POLISH MARKET
Source text for Eikon: ID:nEM9LY4q0a
Further company coverage: GX1.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Genxone SA
See all newsBrief: Genxone Q2 Net Loss 0.3 Million Zlotys
Brief: Genxone 1.2 Mln Zloty Offer For NGS Sequencing Services Chosen As Most Favourable In Tender
Brief: Genxone Signs 93,990 Zloty Contract With Medical University Of Warsaw For Gut Microbiota DNA Sequencing Services
Brief: Genxone Q1 Net Loss 0.5 Million Zlotys
Brief: Genxone FY Net Loss 2.6 Million Zlotys